Analytical strategies for the screening and evaluation of chemically reactive drug metabolites

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Expert Opinion on Drug Metabolism & Toxicology

• Publication date

  2009-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1517/17425250802665706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Analytical strategies for the screening and evaluation of chemically reactive drug metabolites.

  2009cited by this paper
• Screening and characterization of reactive metabolites using glutathione ethyl ester in combination with Q-trap mass spectrometry.

  2009cited by this paper
• Comparison of in vitro bioactivation of flutamide and its cyano analogue: evidence for reductive activation by human NADPH:cytochrome P450 reductase.

  2008cited by this paper
• Dual negative precursor ion scan approach for rapid detection of glutathione conjugates using liquid chromatography/tandem mass spectrometry.

  2008cited by this paper
• Peptide-based in vitro assay for the detection of reactive metabolites.

  2008cited by this paper
• A generic method to detect electrophilic intermediates using isotopic pattern triggered data-dependent high-resolution accurate mass spectrometry.

  2008cited by this paper
• Mass defect profiles of biological matrices and the general applicability of mass defect filtering for metabolite detection.

  2008cited by this paper
• An algorithm for thorough background subtraction from high-resolution LC/MS data: application for detection of glutathione-trapped reactive metabolites.

  2008cited by this paper
• Protein damage by reactive electrophiles: targets and consequences.

  2008cited by this paper
• Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism.

  2008cited by this paper
• Covalent Binding and Tissue Distribution/Retention Assessment of Drugs Associated with Idiosyncratic Drug Toxicity

  2008cited by this paper
• High-throughput screening and characterization of reactive metabolites using polarity switching of hybrid triple quadrupole linear ion trap mass spectrometry.

  2008cited by this paper
• Comparison of the Bioactivation Potential of the Antidepressant and Hepatotoxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug

  2008cited by this paper
• Rapid screening of glutathione-trapped reactive metabolites by linear ion trap mass spectrometry with isotope pattern-dependent scanning and postacquisition data mining.

  2008cited by this paper
• Detection of Novel Reactive Metabolites of Trazodone: Evidence for CYP2D6-Mediated Bioactivation of m-Chlorophenylpiperazine

  2008cited by this paper
• Mitochondrial protein targets of thiol-reactive electrophiles.

  2008cited by this paper
• An algorithm for thorough background subtraction from high-resolution LC/MS data: application to the detection of troglitazone metabolites in rat plasma, bile, and urine.

  2008cited by this paper
• Bioactivation of the tricyclic antidepressant amitriptyline and its metabolite nortriptyline to arene oxide intermediates in human liver microsomes and recombinant P450s.

  2008cited by this paper
• Computational toxicology in drug development.

  2008cited by this paper
• Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications.

  2008cited by this paper
• Minimizing metabolic activation during pharmaceutical lead optimization: progress, knowledge gaps and future directions.

  2008cited by this paper
• Idiosyncratic drug reactions: past, present, and future.

  2008cited by this paper
• Toxicological Significance of Mechanism-Based Inactivation of Cytochrome P450 Enzymes by Drugs

  2007cited by this paper
• Idiosyncratic drug reactions: current understanding.

  2007cited by this paper
• Metabolism of Prazosin in Rat, Dog, and Human Liver Microsomes and Cryopreserved Rat and Human Hepatocytes and Characterization of Metabolites by Liquid Chromatography/Tandem Mass Spectrometry

  2007cited by this paper
• Protein targets of reactive electrophiles in human liver microsomes.

  2007cited by this paper
• Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.

  2007cited by this paper
• In silico prediction of ADMET properties: how far have we come?

  2007cited by this paper
• Detection and structural characterization of glutathione-trapped reactive metabolites using liquid chromatography-high-resolution mass spectrometry and mass defect filtering.

  2007cited by this paper
• Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactions.

  2007cited by this paper
• Capillary LC coupled with high-mass measurement accuracy mass spectrometry for metabolic profiling.

  2007cited by this paper
• Top-down and bottom-up mass spectrometric characterization of human myoglobin-centered free radicals induced by oxidative damage.

  2007cited by this paper
• Tools in metabonomics: an integrated validation approach for LC-MS metabolic profiling of mercapturic acids in human urine.

  2007cited by this paper
• Use of a trapping agent for simultaneous capturing and high-throughput screening of both "soft" and "hard" reactive metabolites.

  2007influential reference
• Response normalized liquid chromatography nanospray ionization mass spectrometry

  2007cited by this paper
• Screening and identification of GSH-trapped reactive metabolites using hybrid triple quadruple linear ion trap mass spectrometry.

  2007cited by this paper
• Applying mechanisms of chemical toxicity to predict drug safety.

  2007cited by this paper
• Bioactivation and hepatotoxicity of nitroaromatic drugs.

  2006cited by this paper
• Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry.

  2006cited by this paper
• Toxicophores: investigations in drug safety.

  2006cited by this paper
• Detection and Characterization of Metabolites in Biological Matrices Using Mass Defect Filtering of Liquid Chromatography/High Resolution Mass Spectrometry Data

  2006cited by this paper
• Cytosolic and nuclear protein targets of thiol-reactive electrophiles.

  2006cited by this paper
• Genomic identification of potential risk factors during acetaminophen-induced liver disease in susceptible and resistant strains of mice.

  2006cited by this paper
• Screening for reactive intermediates and toxicity assessment in drug discovery.

  2006cited by this paper
• A semiquantitative method for the determination of reactive metabolite conjugate levels in vitro utilizing liquid chromatography-tandem mass spectrometry and novel quaternary ammonium glutathione analogues.

  2006cited by this paper
• Future of toxicology-metabolic activation and drug design: challenges and opportunities in chemical toxicology.

  2006cited by this paper
• Utility of the hybrid LTQ-FTMS for drug metabolism applications.

  2006cited by this paper
• Application of a linear ion trap/orbitrap mass spectrometer in metabolite characterization studies: Examination of the human liver microsomal metabolism of the non-tricyclic anti-depressant nefazodone using data-dependent accurate mass measurements

  2006cited by this paper
• Addressing Metabolic Activation as an Integral Component of Drug Design

  2006cited by this paper
• Computational toxicology: heading toward more relevance in drug discovery and development.

  2006cited by this paper
• A review of nanoelectrospray ionization applications for drug metabolism and pharmacokinetics.

  2006cited by this paper
• A quantitative high-throughput trapping assay as a measurement of potential for bioactivation.

  2006cited by this paper
• Ultra-low flow nanospray for the normalization of conventional liquid chromatography/mass spectrometry through equimolar response: standard-free quantitative estimation of metabolite levels in drug discovery.

  2006cited by this paper
• Use of nano-electrospray for metabolite identification and quantitative absorption, distribution, metabolism and excretion studies.

  2006cited by this paper
• Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

  2005cited by this paper
• Rapid detection and identification of N-acetyl-L-cysteine thioethers using constant neutral loss and theoretical multiple reaction monitoring combined with enhanced product-ion scans on a linear ion trap mass spectrometer

  2005cited by this paper
• Proteomic identification of potential susceptibility factors in drug-induced liver disease.

  2005cited by this paper
• A comprehensive listing of bioactivation pathways of organic functional groups.

  2005cited by this paper
• Mechanistic studies on the metabolic scission of thiazolidinedione derivatives to acyclic thiols.

  2005cited by this paper
• In vitro bioactivation of dihydrobenzoxathiin selective estrogen receptor modulators by cytochrome P450 3A4 in human liver microsomes: formation of reactive iminium and quinone type metabolites.

  2005cited by this paper
• Negative ion tandem mass spectrometry for the detection of glutathione conjugates.

  2005influential reference
• A high-throughput liquid chromatography/tandem mass spectrometry method for screening glutathione conjugates using exact mass neutral loss acquisition.

  2005cited by this paper
• Application of stable isotope labeled glutathione and rapid scanning mass spectrometers in detecting and characterizing reactive metabolites.

  2005cited by this paper
• Dansyl glutathione as a trapping agent for the quantitative estimation and identification of reactive metabolites.

  2005cited by this paper
• Role of Metabolism in Drug-Induced Idiosyncratic Hepatotoxicity

  2005cited by this paper
• Metabolic activation of a 1,3-disubstituted piperazine derivative: evidence for a novel ring contraction to an imidazoline.

  2005cited by this paper
• Elucidating mechanisms of drug-induced toxicity

  2005cited by this paper
• Bioactivation of 2,3-diaminopyridine-containing bradykinin B1 receptor antagonists: irreversible binding to liver microsomal proteins and formation of glutathione conjugates.

  2005cited by this paper
• Current trends in drug-induced autoimmunity.

  2005cited by this paper
• Uniformity of ionization response of structurally diverse analytes using a chip-based nanoelectrospray ionization source.

  2005cited by this paper
• Minimizing the potential for metabolic activation as an integral part of drug design.

  2005cited by this paper
• Minimising the potential for metabolic activation in drug discovery

  2005cited by this paper
• Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer.

  2005cited by this paper
• Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance

  2005cited by this paper
• Conversion of the 2,2,6,6-tetramethylpiperidine moiety to a 2,2-dimethylpyrrolidine by cytochrome P450: evidence for a mechanism involving nitroxide radicals and heme iron.

  2004cited by this paper
• Improving the decision-making process in structural modification of drug candidates: reducing toxicity.

  2004cited by this paper
• Stable-isotope trapping and high-throughput screenings of reactive metabolites using the isotope MS signature.

  2004influential reference
• The development of a higher throughput reactive intermediate screening assay incorporating micro-bore liquid chromatography-micro-electrospray ionization-tandem mass spectrometry and glutathione ethyl ester as an in vitro conjugating agent.

  2004cited by this paper
• Acetaminophen‐Induced Hepatotoxicity: Role of Metabolic Activation, Reactive Oxygen/Nitrogen Species, and Mitochondrial Permeability Transition

  2004cited by this paper
• Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development.

  2004cited by this paper
• A software filter to remove interference ions from drug metabolites in accurate mass liquid chromatography/mass spectrometric analyses.

  2003cited by this paper
• Metabolic activation of a pyrazinone-containing thrombin inhibitor. Evidence for novel biotransformation involving pyrazinone ring oxidation, rearrangement, and covalent binding to proteins.

  2003cited by this paper
• An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy.

  2003cited by this paper
• Bioactivation of benzylamine to reactive intermediates in rodents: formation of glutathione, glutamate, and peptide conjugates.

  2002cited by this paper
• Production of intracellular 35S-glutathione by rat and human hepatocytes for the quantification of xenobiotic reactive intermediates.

  2002cited by this paper
• Delineating novel metabolic pathways of DPC 963, a non-nucleoside reverse transcriptase inhibitor, in rats. Characterization of glutathione conjugates of postulated oxirene and benzoquinone imine intermediates by LC/MS and LC/NMR.

  2002cited by this paper
• Biotransformation reactions of five-membered aromatic heterocyclic rings.

  2002cited by this paper
• Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system.

  2002cited by this paper
• Reactive metabolite screen for reducing candidate attrition in drug discovery.

  2001influential reference
• Structure toxicity relationships--how useful are they in predicting toxicities of new drugs?

  2001cited by this paper
• SALSA: a pattern recognition algorithm to detect electrophile-adducted peptides by automated evaluation of CID spectra in LC-MS-MS analyses.

  2001cited by this paper
• Gas chromatography/negative ion chemical ionization mass spectrometry and liquid chromatography/electrospray ionization tandem mass spectrometry quantitative profiling of N-acetylcysteine conjugates of valproic acid in urine: application in drug metabolism studies in humans.

  2000cited by this paper
• Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation

  2000cited by this paper
• Cytochromes P450 and uridine triphosphate‐glucuronosyltransferases: Model autoantigens to study drug‐induced, virus‐induced, and autoimmune liver disease

  1997cited by this paper
• Microsomal metabolism of the 5-lipoxygenase inhibitor L-739,010: evidence for furan bioactivation.

  1996cited by this paper
• Mechanism of acetaminophen-induced hepatotoxicity: covalent binding versus oxidative stress.

  1996cited by this paper
• Quinone methide formation from para isomers of methylphenol (cresol), ethylphenol, and isopropylphenol: relationship to toxicity.

  1995cited by this paper
• Mass spectrometry in the analysis of glutathione conjugates.

  1993influential reference
• Fragmentation characteristic of glutathione conjugates activated by high-energy collisions

  1992cited by this paper
• Trapping of reactive intermediates by incorporation of 14C-sodium cyanide during microsomal oxidation.

  1991cited by this paper

• Feature-Based Molecular Networking Combined with Multivariate Analysis for the Characterization of Glutathione Adducts as a Smoking Gun of Bioactivation.

  2023cites this paper
• A Comprehensive Study to Identify Major Metabolites of an Amoxicillin–Sulbactam Hybrid Molecule in Rats and Its Metabolic Pathway Using UPLC-Q-TOF-MS/MS

  2022cites this paper
• Characteristics of Major Drug Metabolizing Cytochrome P450 Enzymes

  2021cites this paper
• Role of Metabolic Activation in Elemicin-induced Cellular Toxicity.

  2019cites this paper
• Drug metabolism and metabolite safety assessment in drug discovery and development

  2018cites this paper
• Deuterium‐ und tritiummarkierte Verbindungen: Anwendungen in den modernen Biowissenschaften

  2018cites this paper
• Deuterium- and Tritium-Labelled Compounds: Applications in the Life Sciences.

  2018cites this paper
• Synthesis, biological evaluation, and metabolic stability of chlorogenic acid derivatives possessing thiazole as potent inhibitors of α-MSH-stimulated melanogenesis.

  2017cites this paper
• Design, synthesis, and pharmacological evaluation of a novel series of hormone sensitive lipase inhibitor.

  2017cites this paper
• Generic method for the absolute quantification of glutathione S-conjugates: Application to the conjugates of acetaminophen, clozapine and diclofenac.

  2017cites this paper
• Toxicological potential of acyl glucuronides and its assessment.

  2017cites this paper
• RRx-001 Reset: Chemoresensitization via NO-Mediated M1 Macrophage Repolarization

  2017cites this paper
• Kinetics and Mechanism of Bioactivation via S-Oxygenation of Anti-Tubercular Agent Ethionamide by Peracetic Acid.

  2016cites this paper
• Practical approaches to resolving reactive metabolite liabilities in early discovery

  2015cites this paper
• Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study.

  2015cites this paper
• Development of methods for the bioanalysis of RRx-001 and metabolites.

  2014cites this paper
• Post-acquisition analysis of untargeted accurate mass quadrupole time-of-flight MS(E) data for multiple collision-induced neutral losses and fragment ions of glutathione conjugates.

  2014cites this paper
• Identification and mitigation of a reactive metabolite liability associated with aminoimidazoles.

  2014cites this paper
• MS Applications in Support of Medicinal Chemistry Sciences

  2013cites this paper
• Cómo se altera el metabolismo y transporte de glucosa en porfiria experimental crónica y aguda. Una aproximación mecanística

  2013cites this paper
• Screening Reactive Metabolites: Role of Liquid Chromatography–High‐Resolution Mass Spectrometry in Combination with “Intelligent” Data Mining Tools

  2013cites this paper
• Identification of Drug Metabolites

  2012cites this paper
• Liquid chromatography-mass spectrometric multiple reaction monitoring-based strategies for expanding targeted profiling towards quantitative metabolomics.

  2012cites this paper
• Reactions and enzymes in the metabolism of drugs and other xenobiotics.

  2012cites this paper
• LC‐MS in Drug Metabolism and Pharmacokinetics: A Pharmaceutical Industry Perspective

  2012cites this paper
• Pharmacokinetic benefits of 3,4-dimethoxy substitution of a phenyl ring and design of isosteres yielding orally available cathepsin K inhibitors.

  2012cites this paper
• Evidence of the formation of direct covalent adducts of primaquine, 2-tert-butylprimaquine (NP-96) and monohydroxy metabolite of NP-96 with glutathione and N-acetylcysteine.

  2011cites this paper
• Conventional and novel approaches in generating and characterization of reactive intermediates from drugs/drug candidates.

  2011influential citation
• Assessment of reactive metabolites in drug-induced liver injury

  2011cites this paper
• High-resolution chromatography/time-of-flight MSE with in silico data mining is an information-rich approach to reactive metabolite screening.

  2011cites this paper
• Drug Metabolite Profiling and Identification by High-resolution Mass Spectrometry*

  2011cites this paper
• Use of Triple Quadrupole–Linear Ion Trap Mass Spectrometry as a Single LC–MS Platform in Drug Metabolism and Pharmacokinetics Studies

  2011cites this paper
• Revisiting the metabolism of ketoconazole using accurate mass.

  2009cites this paper